按射血分数对心力衰竭进行分类:JACC综述
本综述总结心力衰竭命名的演变,指出射血分数中间范围患者可能从神经激素阻断中获益,类似射血分数严重降低(<40%)者。观察到性别差异,女性获益的射血分数范围高于男性。基于新证据提出修订命名:射血分数降低(<40%)、轻度降低和正常(男性≥55%,女性≥60%)。
要点
- 射血分数中间范围患者可能从神经激素阻断中获益。
- 女性神经激素阻断获益的射血分数范围高于男性。
- 提出修订命名:降低(<40%)、轻度降低、正常(男≥55%,女≥60%)。
核心结论
- 基于新兴证据,建议修订心力衰竭命名以反映射血分数降低、轻度降低和正常,并考虑对射血分数降低或轻度降低患者使用潜在有益治疗。
研究设计与样本
- 本文为JACC综述,总结心力衰竭命名演变并检查相关证据。
主要发现
- 射血分数中间范围患者可能从神经激素阻断中获益,类似射血分数严重降低(<40%)者。
- 女性神经激素阻断获益的射血分数范围高于男性。
关键数值与推荐
- 修订命名定义:射血分数降低(<40%)、轻度降低、正常(男性≥55%,女性≥60%)。
临床怎么用
- 临床应考虑对射血分数降低或轻度降低的患者使用潜在有益治疗,并注意性别差异。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
The recent U.S. Food and Drug Administration expanded indication for sacubitril/valsartan introduces a new potential taxonomy for heart failure, with no reference to "preserved" ejection fraction but referring to "below normal" ejection fraction as those most likely to benefit. This review summarizes the evolution of nomenclature in heart failure and examines evidence showing that patients with ejection fraction in the "mid range" may benefit from neurohormonal blockade similar to those with more severely reduced (<40%) ejection fraction. Furthermore, prominent sex differences have been observed wherein the benefit of neurohormonal blockade appears to extend to a higher ejection fraction range in women compared to men. Based on emerging evidence, revised nomenclature is proposed defining heart failure with "reduced" (<40%), "mildly reduced," and "normal" (≥55% in men, ≥60% in women) ejection fraction. Such nomenclature signals consideration of potentially beneficial therapies in the largest group of patients with reduced or mildly reduced ejection fraction.
引用
- Lam CSP, Solomon SD. Classification of Heart Failure According to Ejection Fraction: JACC Review Topic of the Week. J Am Coll Cardiol. 2021. PMID: 34167646. doi:10.1016/j.jacc.2021.04.070
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。